Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes

Søren Lund, Lise Tarnow, Coen D A Stehouwer, Casper G Schalkwijk, Tom Teerlink, Jørgen Brodersen Gram, Kaj Winther, Merete Müermann Frandsen, Ulla M Smidt, Oluf Pedersen, Hans-Henrik Parving, Allan A Vaag

    88 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab